The Indian Pharmacopoeia Commission (IPC) invites applications for the 29th Skill Development Programme on Pharmacovigilance

The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health & Family Welfare, Government of India, responsible for setting standards for drugs in the country through the Indian Pharmacopoeia (IP).

The 29th Skill Development Programme on Pharmacovigilance is an initiative by IPC aimed at enhancing skills and knowledge in the field of pharmacovigilance, which is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems.

The program is scheduled to take place from 3rd to 7th June 2024. During this period, participants will engage in workshops, lectures, and other interactive sessions to gain insights into various aspects of pharmacovigilance.

To attend the program, interested individuals must register by paying a fee of Rs. 1000/- only. This fee likely covers the costs of organizing the program, including venue, materials, and facilitators’ expenses.

Overall, the Skill Development Programme on Pharmacovigilance offers an opportunity for professionals and students in the pharmaceutical field to enhance their understanding and skills in ensuring the safety and efficacy of drugs, contributing to the overall improvement of healthcare standards in India.

Who can apply?

  • Pharmacists
  • Nurses
  • Doctors
  • Pharmacy/pharm D students
  • MBBS/BDS/nursing students
  • Young professionals in pharmacovigilance
  • Academicians
  • Industry professionals
  • Consumers/NGOs
  • Volunteer Application

  •  

For further details, please contact:

Registration deadline: May 27, 2024

Payment mode: NEFT

Bank account details:

  • Indian Pharmacopoeia Commission
  • Bank of Baroda
  • Sanjay Nagar, Ghaziabad
  • Account number: 21860100013540
  • IFSC code: BARBOSANGHA (the fifth character is zero)
  • Type of account: Super Saving
  • MICR code: 110012204

Apply here:

https://docs.google.com/forms/d/e/1FAIpQLScHmMo9K7JQ1kNYCH7cM6Mc5H5hpUILoNOmtt5n0zZwAbGyDQ/viewform?pli=1

Team

pharmaacademias.com and pharmaacademias.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Drugs used in Congestive heart failure

Definition Congestive heart failure (CHF) is a chronic medical condition characterized by the heart’s inability to pump blood efficiently, leading to inadequate circulation and a buildup of fluid in the lungs and other tissues. It is often a progressive condition that can affect the heart’s ability to meet the body’s oxygen and nutrient needs. Classification […]

Epilepsy: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management

Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. Seizures are episodes of abnormal electrical activity in the brain that lead to various symptoms, ranging from brief periods of unconsciousness to unusual movements or sensations. Etiopathogenesis: 1. Idiopathic (Primary) Epilepsy: No identifiable cause; likely genetic factors play a role. 2. Symptomatic (Secondary) Epilepsy: Structural […]

Pregnancy

Pregnancy is a biological process in which a woman’s body nurtures the development of one or more offspring within the uterus. It is initiated by the fertilization of an egg by sperm, leading to the formation of a zygote, which undergoes successive stages of development. Key Stages of Pregnancy 1.Fertilization Fertilization typically occurs in the […]